The supply chain poses a number of challenges for hospitals and health systems, and is often at the focal point of efforts to eliminate waste and reduce spending. A recent survey from MHI and Deloitte narrows in on the top…
Supply Chain
(Dallas -- May 19, 2016) -- Sterilis LLC, an innovative on-site point of care medical waste remediation company, is making its first appearance at the Ambulatory Surgery Center Association (ASCA) show in Dallas on May 19th. At the event, Sterilis…
Studies have shown that supply chain represents 40 to 50 percent of a hospital’s operating expensive.
B. Braun Medical, a German device maker with U.S. headquarters in Bethlehem, Pa., is set to pay up to $7.8 million to resolve its criminal liability for selling contaminated pre-filled saline flush syringes in 2007, which allegedly led to infections…
Irving, Texas-based Vizient, the largest member-owned healthcare company in the U.S., has selected the University of Vermont Medical Center in Burlington to receive its President's Award of Honor for performance-related achievements in its supply chain during 2015.
Advertisement
Asheville, N.C.-based Capstone Health Alliance is now a member of the Healthcare Supply Chain Association, which represents the nation's leading healthcare group purchasing organizations.
Lebanon, N.H.-based Dartmouth-Hitchcock; San Francisco-based Dignity Health; La Crosse, Wis.-based Gundersen Health System; and Boston-based Partners HealthCare have collaborated with Health Care Without Harm and Practice Greenhealth to create a new marketplace for healthy and environmentally safe products.
In a recent press release, Gartner, Inc. has announced the winners of the 2016 Supply Chainnovator Awards. The awards recognize innovative and high-impact supply chain initiatives in the healthcare, high-tech manufacturing and consumer/retail sectors.
Gartner has selected fives companies that excelled in developing and implementing high-impact supply chain initiatives as winners of its 2016 Supply Chainnovator Awards.
The high prices of chemotherapy drugs and the financial burden they pose on public programs, private insurers and patients is a major source of concern. However, addressing this problem through changes to drug negotiation rules, reimportation, price controls or patent…